药品输送市场基于(主要区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00007628
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Pharmaceutical Drug Delivery Market Size & CAGR by 2031

Buy Now

2023年药品给药市场规模预计为17.4亿美元,预计到2031年将达到31.5亿美元;预计到 2031 年,复合年增长率将达到 7.7%。战略发展和产品发布可能仍然是药物输送市场的关键趋势。

 

药品给药市场分析

老年人口的增加、家庭医疗保健的增加、慢性病患病率的增加、外科手术的增加以及传染病患病率的增加正在推动药品给药市场的增长。此外,FDA对各种无创给药装置的批准增加以及制药公司用于药物开发的研发支出的增加也刺激了对药物给药的需求。

 

药物输送市场概况

药物输送系统主要用于控制或靶向输送各种治疗剂,以治疗各种疾病或改善患者的健康。中国是药物输送市场的主要新兴市场之一。中国药物输送设备市场受到医疗器械行业技术进步以及成年人和老年人对慢性病诊断和治疗关注度增加的推动。预计在预测期内,中国将为本地和国际参与者提供在该国制造和销售药物输送设备的丰厚机会。

 

定制研究以满足您的需求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

药物输送市场:

医药给药市场
  • Pharmaceutical Drug Delivery Market
    年均复合增长率(2023 - 2031)
    7.7%
  • 2023 年市场规模
    17.4 亿美元
  • 2031年市场规模
    31.5亿美元

市场动态

增长动力
  • 慢性病和传染病发病率不断上升
  • 对非侵入性药物输送的需求不断增加
未来的趋势
  • XXXXXX
  • XXXXXX
  • XXXXXX
机会
  • 专注于提高患者依从性

关键人物;主力;重要一员

  • 辉瑞公司
  • 拜耳公司
  • 强生服务公司
  • 诺华公司
  • 3M
  • 屋宇署
  • 赛诺菲
  • 默克集团
  • 葛兰素史克公司
  • 安塔雷斯制药

区域概况

Pharmaceutical Drug Delivery Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Pharmaceutical Drug Delivery Market给药途径
  • 口服药物输送
  • 注射药物输送
  • 局部给药
  • 眼部药物输送
  • 肺部药物输送
  • 鼻腔给药
  • 经粘膜给药
  • 植入式药物输送
Pharmaceutical Drug Delivery Market应用
  • 传染性疾病
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸疾病
  • 中枢神经系统疾病
  • 自身免疫性疾病
  • 其他的
Pharmaceutical Drug Delivery Market最终用户
  • 医院
  • 家庭护理设置
  • ASC 和诊所
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

药物输送市场驱动因素和机遇

 

对非侵入性药物输送的需求不断增加

非侵入性药物输送通常涉及通过粘膜表面或皮肤的生物屏障进行无痛药物输送的方法。这种药物输送方法可以增加获得药物的机会,提高药物安全性,并坚持治疗方案。患者更喜欢非侵入性药物输送途径,因为与注射给药相比,非侵入性药物输送途径具有优势,例如不会因针头而受伤和感染,并且非侵入性输送途径具有成本效益。一些最流行的非侵入性药物输送方法是:局部、透皮被动、透皮主动(设备辅助增强渗透)、经粘膜、经眼膜和通过肺泡膜吸入药物输送。使用非侵入性方法的药物输送涉及减少给药频率和简化给药时间表。此外,这些输送系统可以显着降低临床使用成本,因为患者可以通过这些方法自行给药。因此,对非侵入性药物输送系统日益增长的需求推动了药物输送系统市场的增长。

 

专注于提高患者依从性——药品给药市场的机遇

 

患者依从性低是医生和医疗设备制造商的一个值得注意的问题。因此,制造商专注于开发直观且用户友好的药物输送系统,为患者提供高舒适度。患者、护理人员和医生寻求更多以患者为中心的解决方案,评估输送系统和包装选项,以鼓励患者按照指示服用药物。准确测量的剂量和易于使用且带有清晰标签的包装对于满足当今的自给自足需求至关重要。单位剂量包装或容器被精确地填充以容纳用于单剂量的数量的药物。这些功能减少了用药错误,因为药物的身份很快得到确认,并且包装可确保患者服用正确剂量的药物。药品制造商现在专注于药物输送系统,该系统为患者在家里以外的地方服用药物提供易用性、便携性和便利性。研究发现,通过非侵入性方法给药时,患者的依从性要高得多,因为他们在手术过程中感受到的疼痛减轻了。

 

药品给药市场报告细分分析

有助于得出药物输送市场分析的关键部分是给药途径、应用和最终用户。

  • 根据给药途径,药物给药市场分为口服给药、注射给药、局部给药、眼部给药、肺部给药、鼻腔给药、经粘膜给药和植入式给药。 2023 年,注射给药领域占据最大的市场份额。
  • 按应用划分,药物输送市场分为传染病、癌症、心血管疾病、糖尿病、呼吸系统疾病、中枢神经系统疾病、自身免疫性疾病等。 2023 年,癌症细分市场占据最大的市场份额。
  • 根据最终用户,药物输送市场分为医院、家庭护理机构、ASC 和诊所等。医院部门在 2023 年占据了最大的市场份额。

 

药品配送市场份额按地区分析

药物输送市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美主导了药物输送市场。北美市场的增长特点是患者对传染病药物的需求增加、主要市场参与者的存在、产品推出的增加、慢性病患病率的增加以及学术和研究机构和制药公司进行的广泛研发。由于技术进步,输液疗法可以安全有效地在家中进行管理。家庭护理环境中的输液疗法已发展成为一种完全具有成本效益的治疗方法,并导致了医院或专业护理机构住院治疗的产生,从而推动了北美药物输送市场的增长。此外,预计亚太地区将在未来几年录得最高复合年增长率。 

 

药品给药市场报告范围

报告属性细节
2023年市场规模17.4亿美元
2031 年市场规模31.5亿美元
全球复合年增长率(2023 - 2031)7.7%
历史数据2021-2022
预测期2024 - 2031
涵盖的细分市场按给药途径
  • 口服药物输送
  • 注射药物输送
  • 局部给药
  • 眼部药物输送
  • 肺部药物输送
  • 鼻腔给药
  • 经粘膜给药
  • 植入式药物输送
按应用
  • 传染性疾病
  • 癌症
  • 心血管疾病
  • 糖尿病
  • 呼吸疾病
  • 中枢神经系统疾病
  • 自身免疫性疾病
  • 其他的
按最终用户
  • 医院
  • 家庭护理设置
  • ASC 和诊所
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 辉瑞公司
  • 拜耳公司
  • 强生服务公司
  • 诺华公司
  • 3M
  • 屋宇署
  • 赛诺菲
  • 默克集团
  • 葛兰素史克公司
  • 安塔雷斯制药
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

药品给药市场新闻和最新动态

药物输送市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是药物输送市场的发展和策略列表:

  • Stevanato Group 与 Recipharm 合作开发和制造预填充注射器,该注射器将集成到新型软雾吸入器中,用于吸入敏感的生物制品。新的战略合作旨在为使用 Recipharm 专有的软雾吸入器的制药和生物制药公司提供创新的初级包装。 (来源:斯蒂瓦那托集团,公司网站,2023 年)
  • Coherus BioSciences, Inc 已推出其 UDENYCA 随身注射器 (OBI),该注射器采用 LTS Sorrel 可穿戴药物输送平台。UDENYCA (pegfilgrastim-cbqv) 是一种生物仿制药,在化疗后第二天给药,以降低发热性中性粒细胞减少症所表现的感染发生率。(来源:Cision US Ltd,新闻稿,2024 年)

 

医药药物输送市场报告覆盖范围和交付成果

“药物输送市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..